Cargando…
Tumor Marker Decline in Predicting Treatment Outcome among Poor-Risk Testicular Germ Cell Tumors—A Tertiary Cancer Center Data
Introduction Testicular germ cell tumors are rare in India. Despite the advances in chemotherapy, poor-risk testicular nonseminomatous germ cell tumors (NSGCT) remain as a clinical challenge. Various prognostic factors have been described in this rare disease. The Indian data in this regard is scar...
Autores principales: | K., Lakshmi Haridas, James, Francis V., Kumar, Aswin, Joseph, John, KM, Jagathnath Krishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803541/ https://www.ncbi.nlm.nih.gov/pubmed/36588617 http://dx.doi.org/10.1055/s-0042-1743423 |
Ejemplares similares
-
Prognostic factors and outcomes of nonseminomatous germ cell tumours of testis—experience from a tertiary cancer centre in India
por: Nair, Lekha Madhavan, et al.
Publicado: (2020) -
Management of poor-prognosis testicular germ cell tumors
por: Khurana, Kiranpreet, et al.
Publicado: (2010) -
Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021) -
βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
por: Chovanec, Michal, et al.
Publicado: (2018) -
Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020)